ALPS Medical Breakthroughs ETF
SBIO
45 hedge funds and large institutions have $65M invested in ALPS Medical Breakthroughs ETF in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
146% more call options, than puts
Call options by funds: $917K | Put options by funds: $373K
44% more capital invested
Capital invested by funds: $45.1M → $65M (+$19.9M)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
7% more funds holding
Funds holding: 42 → 45 (+3)
4.23% more ownership
Funds ownership: 25.58% → 29.8% (+4.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$5.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5.49M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.45M |
| 4 |
Morgan Stanley
New York
|
+$1.21M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1.45M |
| 2 |
Jane Street
New York
|
-$635K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$392K |
| 4 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
-$56.7K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$28K |
SBIO Hedge Fund Activity: Q2 2018 in Review
45 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2018, worth a combined $65M — up 44% from $45.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SBIO positions and 7 closed out — a net gain of 3 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was Bank of America, adding an estimated $5.6M. The largest seller was Virtu Financial, exiting entirely with an estimated $1.45M sold.
- 45 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2018, up from 42 in Q1 2018.
- Funds reported $65M of ALPS Medical Breakthroughs ETF stock for Q2 2018, up 44% quarter-over-quarter.
- 10 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2018 and 7 closed out, a net change of +3 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q2 2018 was Bank of America, an estimated $5.6M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q2 2018 was Virtu Financial, an estimated $1.45M sold.
Based on aggregated 13F filings for Q2 2018.